1. Declining Morbidity and Mortality among Patients with Advanced Human Immunodeficiency Virus Infection
2. Increasing Choices for HIV Therapy
3. 3 S Kaul, B Damle, and J Gale et al. Pharmacokinetics (PK) of stavudine (d4T) extended release (XR) formulation compared with stavudine immediate release (IR) formulation as part of potent antiretroviral combination therapy.9th Conference on Retroviruses and Opportunistic Infections. Seattle, WA, February 2002 [Abstract 430-W].
4. 4 H Brett-Smith, L Reynolds, L Bessen, and V Rutkiewicz . Two-year analysis of stavudine extended-release/prolonged release capsules (XR/PRC) as compared to stavudine immediate-release (IR) efficacy and safety.43rd Annual Interscience Conference on Antimicrobial Agents and Chemotherapy. Chicago, IL, September 2003 [Abstract H843].
5. 5 M Thompson, G Richmond, and H Kesseler et al. Preliminary results of dosing of amdoxivir in treatment-experienced patients.10th Conference on Retroviruses and Opportunistic Infections. Boston, MA, February 2003 [Abstract 55].